Correction: Kohsaka et al. Risk–Benefit Balance of Renin–Angiotensin–Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia. J. Clin. Med. 2022, 11, 5828

Detalles Bibliográficos
Autores principales: Kohsaka, Shun, Okami, Suguru, Morita, Naru, Yajima, Toshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095320/
https://www.ncbi.nlm.nih.gov/pubmed/37048834
http://dx.doi.org/10.3390/jcm12072578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095320/
https://www.ncbi.nlm.nih.gov/pubmed/37048834
http://dx.doi.org/10.3390/jcm12072578

Ejemplares similares